TACSTD2 and neoplasm: In vivo evaluations indicated that 64Cu-labeled hIMB1636 could noninvasively assess Trop2 expression levels using positron emission tomography (PET) imaging, and 177Lu-labeled hIMB1636 significantly suppressed tumor growth in Trop2-overexpressing T3M-4 mouse models 94.